1st Quarter - Termination
THE WERNER GROUP for SHIRE PHARMACEUTICALS
Firm
Client
Income
$20,000
Expenses
—
Terminated
Feb 28, 2009
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
HR 1548 Pathway for Biosimilars Act -- focus on orphan drug issues HR 1427 Promoting Innovation and Access to Life Saving Medicine Act -- focus on orphan drug issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL WERNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.